Balchem (BCPC) EBITDA (2010 - 2026)

Balchem (BCPC) has 17 years of EBITDA data on file, last reported at $55.6 million in Q1 2026.

• EBITDA for Q1 2026 came in at $55.6 million, up 9.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.9 million (up 11.28% YoY), and the FY2025 annual result was $209.3 million, up 14.44% from the prior year.
• EBITDA improved to $55.6 million in Q1 2026 per BCPC's latest filing, from $52.3 million in the prior quarter.
• Over five years, EBITDA peaked at $55.6 million in Q1 2026 and troughed at $33.3 million in Q4 2022.
• A 5-year average of $44.2 million and a median of $43.6 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2023: EBITDA surged 30.49% in 2022, then declined 10.25% in 2023.
• A 5-year view of EBITDA shows it stood at $33.3 million in 2022, then rose by 15.1% to $38.3 million in 2023, then climbed by 23.76% to $47.4 million in 2024, then rose by 10.21% to $52.3 million in 2025, then grew by 6.38% to $55.6 million in 2026.
• Business Quant data shows BCPC's EBITDA at $55.6 million in Q1 2026, $52.3 million in Q4 2025, and $54.6 million in Q3 2025.